Healthcare provider profile · identity verified

Ilaxi Patel, D.O.

Internal Medicine · SYCAMORE, IL · NPI 1629087861

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	816	216
Levothyroxine Sodium	Levothyroxine Sodium	619	144
Rosuvastatin Calcium	Rosuvastatin Calcium	498	118
Atorvastatin Calcium	Atorvastatin Calcium	481	121
Lisinopril	Lisinopril	424	97
Losartan Potassium	Losartan Potassium	335	90
Metformin Hcl Er	Metformin Hcl	256	64
Metoprolol Tartrate	Metoprolol Tartrate	255	55
Gabapentin	Gabapentin	251	67
Metoprolol Succinate	Metoprolol Succinate	241	57
Simvastatin	Simvastatin	239	64
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	205	58
Omeprazole	Omeprazole	203	37
Pantoprazole Sodium	Pantoprazole Sodium	196	59
Famotidine	Famotidine	188	65
Alprazolam	Alprazolam	183	85
Ezetimibe	Ezetimibe	182	37
Hydrochlorothiazide	Hydrochlorothiazide	180	50
Jardiance	Empagliflozin	179	39
Atenolol	Atenolol	178	50
Furosemide	Furosemide	174	36
Montelukast Sodium	Montelukast Sodium	171	45
Alendronate Sodium	Alendronate Sodium	161	39
Duloxetine Hcl	Duloxetine Hcl	159	44
Fluticasone Propionate	Fluticasone Propionate	155	62
Tramadol Hcl	Tramadol Hcl	143	44
Escitalopram Oxalate	Escitalopram Oxalate	138	42
Ozempic	Semaglutide	136	20
Potassium Chloride	Potassium Chloride	134	35
Metformin Hcl	Metformin Hcl	126	36
Sertraline Hcl	Sertraline Hcl	114	32
Memantine Hcl	Memantine Hcl	111	suppressed
Pravastatin Sodium	Pravastatin Sodium	111	29
Albuterol Sulfate Hfa	Albuterol Sulfate	110	46
Carvedilol	Carvedilol	107	25
Glimepiride	Glimepiride	105	28
Hydralazine Hcl	Hydralazine Hcl	104	27
Allopurinol	Allopurinol	95	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	94	30
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	91	48
Tamsulosin Hcl	Tamsulosin Hcl	84	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	83	21
Warfarin Sodium	Warfarin Sodium	75	21
Eliquis	Apixaban	73	28
Citalopram Hbr	Citalopram Hydrobromide	58	18
Cephalexin	Cephalexin	57	42
Enalapril Maleate	Enalapril Maleate	57	15
Lovastatin	Lovastatin	55	16
Synthroid	Levothyroxine Sodium	55	17
Donepezil Hcl	Donepezil Hcl	53	suppressed
Bupropion Hcl Sr	Bupropion Hcl	52	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	52	18
Fluoxetine Hcl	Fluoxetine Hcl	50	11
Glipizide Er	Glipizide	49	suppressed
Myrbetriq	Mirabegron	48	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	48	23
Methylprednisolone	Methylprednisolone	47	47
Nifedipine Er	Nifedipine	47	suppressed
Trazodone Hcl	Trazodone Hcl	47	21
Clonazepam	Clonazepam	46	24
Clopidogrel	Clopidogrel Bisulfate	44	13
Spironolactone	Spironolactone	41	suppressed
Azithromycin	Azithromycin	40	37
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	40	25
Fenofibrate	Fenofibrate Nanocrystallized	40	13
Carbamazepine Er	Carbamazepine	39	suppressed
Nystatin	Nystatin	39	22
Topiramate	Topiramate	39	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Nabumetone	Nabumetone	37	29
Ropinirole Hcl	Ropinirole Hcl	37	13
Levetiracetam	Levetiracetam	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	32
Bupropion Xl	Bupropion Hcl	35	14
Lorazepam	Lorazepam	35	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	33
Jantoven	Warfarin Sodium	34	suppressed
Meloxicam	Meloxicam	34	16
Tresiba Flextouch U-200	Insulin Degludec	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Glipizide	Glipizide	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Solifenacin Succinate	Solifenacin Succinate	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Meclizine Hcl	Meclizine Hcl	28	17
Tresiba Flextouch U-100	Insulin Degludec	28	12
Midodrine Hcl	Midodrine Hcl	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Prednisone	Prednisone	26	19
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	21
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	23	suppressed
Hydrocortisone	Hydrocortisone	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Tradjenta	Linagliptin	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	21	17
Valsartan	Valsartan	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Memantine Hcl Er	Memantine Hcl	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Temazepam	Temazepam	20	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Galantamine Hbr	Galantamine Hbr	18	suppressed
Torsemide	Torsemide	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Amoxicillin	Amoxicillin	15	11
Baclofen	Baclofen	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Digoxin	Digoxin	15	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Bethanechol Chloride	Bethanechol Chloride	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Sotalol Af	Sotalol Hcl	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Risperidone	Risperidone	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	12	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Invokana	Canagliflozin	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Nystop	Nystatin	11	suppressed
Tirosint	Levothyroxine Sodium	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error